These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25459762)

  • 1. Lessons from molecular modeling human α-L-iduronidase.
    Figueiredo DF; Antunes DA; Rigo MM; Mendes MF; Silva JP; Mayer FQ; Matte U; Giugliani R; Vieira GF; Sinigaglia M
    J Mol Graph Model; 2014 Nov; 54():107-13. PubMed ID: 25459762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and clinical implications of amino acid substitutions in α-L-iduronidase: insight into the basis of mucopolysaccharidosis type I.
    Saito S; Ohno K; Maita N; Sakuraba H
    Mol Genet Metab; 2014 Feb; 111(2):107-12. PubMed ID: 24480078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and molecular characterization of alpha-L-iduronidase mutations present in mucopolysaccharidosis type I patients undergoing enzyme replacement therapy.
    Yogalingam G; Guo XH; Muller VJ; Brooks DA; Clements PR; Kakkis ED; Hopwood JJ
    Hum Mutat; 2004 Sep; 24(3):199-207. PubMed ID: 15300847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A homology model for human alpha-l-iduronidase: insights into human disease.
    Rempel BP; Clarke LA; Withers SG
    Mol Genet Metab; 2005 May; 85(1):28-37. PubMed ID: 15862278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c.1898C>G/p.Ser633Trp Mutation in Alpha-L-Iduronidase: Clinical and Structural Implications.
    Peña-Gomar I; Jiménez-Mariscal JL; Cerón M; Rosas-Trigueros J; Reyes-López CA
    Protein J; 2021 Feb; 40(1):68-77. PubMed ID: 33389473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into mucopolysaccharidosis I from the structure and action of α-L-iduronidase.
    Bie H; Yin J; He X; Kermode AR; Goddard-Borger ED; Withers SG; James MN
    Nat Chem Biol; 2013 Nov; 9(11):739-45. PubMed ID: 24036510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
    Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
    Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of mucopolysaccharidosis I heterozygotes based on biochemical characteristics of L-iduronidase from dried blood spots.
    Campos D; Monaga M; González EC; Herrera D
    Clin Chim Acta; 2014 Mar; 430():24-7. PubMed ID: 24389097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant encapsulated cells overexpressing alpha-L-iduronidase correct enzyme deficiency in human mucopolysaccharidosis type I cells.
    Baldo G; Quoos Mayer F; Burin M; Carrillo-Farga J; Matte U; Giugliani R
    Cells Tissues Organs; 2012; 195(4):323-9. PubMed ID: 21778683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant alpha-L-iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts.
    Unger EG; Durrant J; Anson DS; Hopwood JJ
    Biochem J; 1994 Nov; 304 ( Pt 1)(Pt 1):43-9. PubMed ID: 7998955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sexual behaviour in a murine model of mucopolysaccharidosis type I (MPS I).
    Barbosa Mendes A; do Nascimento CC; D'Almeida V
    PLoS One; 2019; 14(12):e0220429. PubMed ID: 31834922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel p.E276K IDUA mutation decreasing α-L-iduronidase activity causes mucopolysaccharidosis type I.
    Prommajan K; Ausavarat S; Srichomthong C; Puangsricharern V; Suphapeetiporn K; Shotelersuk V
    Mol Vis; 2011 Feb; 17():456-60. PubMed ID: 21364962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients.
    Hein LK; Bawden M; Muller VJ; Sillence D; Hopwood JJ; Brooks DA
    J Mol Biol; 2004 Apr; 338(3):453-62. PubMed ID: 15081804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human alpha-L-iduronidase: cDNA isolation and expression.
    Scott HS; Anson DS; Orsborn AM; Nelson PV; Clements PR; Morris CP; Hopwood JJ
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9695-9. PubMed ID: 1946389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel compound mutation in alpha-L-iduronidase gene causes mucopolysaccharidosis type I.
    Li Y; Tang X; Meng Y; Luo G; Yu X
    J Genet; 2019 Sep; 98():. PubMed ID: 31544795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and downstream mannose phosphorylation of human recombinant α-L-iduronidase produced in Arabidopsis complex glycan-deficient (cgl) seeds.
    He X; Pierce O; Haselhorst T; von Itzstein M; Kolarich D; Packer NH; Gloster TM; Vocadlo DJ; Qian Y; Brooks D; Kermode AR
    Plant Biotechnol J; 2013 Dec; 11(9):1034-43. PubMed ID: 23898885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of lysosomal storage in brain of adult MPS-I mice with intravenous Trojan horse-iduronidase fusion protein.
    Boado RJ; Hui EK; Lu JZ; Zhou QH; Pardridge WM
    Mol Pharm; 2011 Aug; 8(4):1342-50. PubMed ID: 21667973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel compound heterozygous IDUA mutation underlies Mucopolysaccharidoses type I in a Chinese pedigree.
    Zhou YA; Li P; Zhang Y; Xiong Q; Li C; Zhao Z; Wang Y; Xiao H
    Mol Genet Genomic Med; 2020 Jan; 8(1):e1058. PubMed ID: 31758674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-glycan structures and downstream mannose-phosphorylation of plant recombinant human alpha-L-iduronidase: toward development of enzyme replacement therapy for mucopolysaccharidosis I.
    Pierce OM; McNair GR; He X; Kajiura H; Fujiyama K; Kermode AR
    Plant Mol Biol; 2017 Dec; 95(6):593-606. PubMed ID: 29119347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-L-iduronidase and enzyme replacement therapy for mucopolysaccharidosis I.
    Brooks DA
    Expert Opin Biol Ther; 2002 Dec; 2(8):967-76. PubMed ID: 12517274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.